跳至主要内容
临床试验/NCT04949165
NCT04949165已完成不适用

Iron Supplementation and Nutritional Counseling Interventions to Improve Availability and Safety of Blood in Ghana

University of Minnesota1 个研究点 分布在 1 个国家目标入组 223 人开始时间: 2021年9月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
223
试验地点
1
主要终点
Haemoglobin Level

研究概览

简要总结

This pilot study has 2 components: 1) a cross-sectional assessment designed to estimate the prevalence of anaemia leading to donor deferral, the prevalence of iron deficiency (ID) and iron deficiency anaemia (IDA) among first-time donors, and 2) a longitudinal 2-arm parallel groups trial among first- time voluntary donors that compares haemoglobin levels at 4 months among those with ID or IDA who receive iron supplementation to those without ID or IDA who do not receive iron supplementation. A structured questionnaire will be used to extract demographic characteristics. Participants will be followed for a total of 6 months with study visits at 2, 4 and 6 months after the baseline assessments. Blood draws for full blood count (FBC), peripheral film comment, malaria rapid diagnostic tests (RDT) and ferritin assessment will occur at baseline and all follow-up visits. In addition, we will use a qualitative approach to identify barriers and facilitators of blood donation and the use of dietary and iron supplementation strategies to address iron deficiency and/or anaemia. This will involve conducting focus group discussions during the last month of the intervention and key informant interviews.

Expected Outcomes The expected outcomes of the study have been grouped into two, primary and secondary. Primary Outcome will be haemoglobin level after 4 months. Secondary Outcomes are A. Change in haemoglobin levels B. Diagnosis of ID or IDA at 4 months C. Serum ferritin concentration after 4 months of intervention D. Acceptability of iron supplementation among participants and stakeholders E. Incidence of gastrointestinal adverse events F. Incidence of suspected malaria or bacterial infections G. Incidence of ID and IDA H. Successful return (non-deferred) to the blood donor pool after intervention within 6 months of enrolment I. Key barriers and facilitators of intervention implementation.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
17 Years 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females aged between 17 and 60 years who weigh at least 50kg.
  • Pass pre-donation screening using the NBSG standardised donor screening questionnaire for medical conditions and lifestyle risks for transfusion transmissible infections
  • Vital signs must meet the NBSG requirement for blood donation: systolic and diastolic blood pressures between 90-140 mmHg and 60- 90 mmHg, respectively; pulse rate between 50-100 bpm; non-contact forehead temperature not exceeding 37.5°C; meeting acceptable requirements for skin lesions, needle marks and physical appearance.
  • Must be willing and able to give study consent or assent.
  • Intend to remain in the study location/site during the entire length of the study.

排除标准

  • Persons who have used iron supplementation within the past one month.
  • Participant reports having previously donated blood.
  • Evidence for a TTI at baseline among those who successfully donated.
  • Evidence of Malaria and helminthic infections at baseline
  • Participants who have Hb <10g/dl at screening

结局指标

主要结局

Haemoglobin Level

时间窗: 4 months

Haemoglobin level at 4 months from the enrollment visit.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验